CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...

BRIDGEPORT — Hartford HealthCare's St. Vincent's Medical Center has received a $15 million commitment to expand and modernize ...

Thousands of people in England with a type of multiple sclerosis (MS) are set to benefit from a new treatment on the ...

Learn how to rapidly identify, manage, and prevent drowning injuries using updated evidence-based approaches from prehospital care to ICU management.

Baxter International Inc. (NYSE:BAX) is one of the top cheap stocks under $20 to buy now. On December 12, Wells Fargo analyst ...

Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

Kavita Mehta suffers from beta thalassaemia, a genetic condition preventing her body from producing sufficient haemoglobin ...

A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a major blood disorder. Kavita Mehta, 36, from London, has beta thalassaemia, ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...